{'fraction_non_alphanumeric': 0.019083969465648856, 'fraction_numerical': 0.008905852417302799, 'mean_word_length': 5.346774193548387, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Use of autologous blood mononuclear cells in the complex treatment of corneal ulcers].

A new method was developed to treat corneal ulcers with instillations of autologous blood mononuclear cells during traditional pharmacotherapy. Clinical trials showed a significantly more arrest of an exudative-destructive reaction: the time of ulcerative defect debridement from necrotic masses reduced by 1.5-2 times, resolution of a perifocal edema and infiltration by 1.6 times. There was simultaneously an acceleration of transition of inflammation to a phase of reparation with the formation of corneal opacity of less intensity and dimension. Instillations of autologous blood mononuclear cells showed a 4.4-fold reduction in the total number of complications as compared with the controls.